E
Aion Therapeutic Inc.
AION
CNSX
E
Sell
11/11/2024Downgrade
Aion Therapeutic Inc. (AION) was downgraded to E+ from D- on 11/11/2024 due to a significant decline in the solvency index and growth index. Earnings per share declined from -$0.0009 to -$0.0098, operating cash flow declined 430.8% from $180.2 to -$596.1, and EBIT declined 107.52% from -$170.3 to -$353.4.
Aion Therapeutic Inc. (AION) was downgraded to E+ from D- on 11/11/2024 due to a significant decline in the solvency index and growth index. Earnings per share declined from -$0.0009 to -$0.0098, operating cash flow declined 430.8% from $180.2 to -$596.1, and EBIT declined 107.52% from -$170.3 to -$353.4.
D
Sell
11/6/2024Upgraded
Aion Therapeutic Inc. (AION) was upgraded to D- from E+ on 11/6/2024 due to a substantial increase in the solvency index, total return index and growth index. The quick ratio increased from 0.01 to 0.1, operating cash flow increased 657.89% from -$32.3 to $180.2, and EBIT increased 14.08% from -$198.2 to -$170.3.
Aion Therapeutic Inc. (AION) was upgraded to D- from E+ on 11/6/2024 due to a substantial increase in the solvency index, total return index and growth index. The quick ratio increased from 0.01 to 0.1, operating cash flow increased 657.89% from -$32.3 to $180.2, and EBIT increased 14.08% from -$198.2 to -$170.3.
E
Sell
7/25/2023Downgrade
Aion Therapeutic Inc. (AION) was downgraded to E+ from D- on 7/25/2023 due to a decline in the volatility index.
Aion Therapeutic Inc. (AION) was downgraded to E+ from D- on 7/25/2023 due to a decline in the volatility index.
D
Sell
7/10/2023Upgraded
Aion Therapeutic Inc. (AION) was upgraded to D- from E+ on 7/10/2023 due to a noticeable increase in the solvency index, volatility index and total return index.
Aion Therapeutic Inc. (AION) was upgraded to D- from E+ on 7/10/2023 due to a noticeable increase in the solvency index, volatility index and total return index.
E
Sell
1/4/2023Downgrade
Aion Therapeutic Inc. (AION) was downgraded to E+ from D- on 1/4/2023 due to a noticeable decline in the solvency index and volatility index. The quick ratio declined from 0.08 to 0.08.
Aion Therapeutic Inc. (AION) was downgraded to E+ from D- on 1/4/2023 due to a noticeable decline in the solvency index and volatility index. The quick ratio declined from 0.08 to 0.08.
D
Sell
11/8/2022Upgraded
Aion Therapeutic Inc. (AION) was upgraded to D- from E+ on 11/8/2022 due to a noticeable increase in the growth index and valuation index. Operating cash flow increased 111.89% from -$77.4 to $9.2.
Aion Therapeutic Inc. (AION) was upgraded to D- from E+ on 11/8/2022 due to a noticeable increase in the growth index and valuation index. Operating cash flow increased 111.89% from -$77.4 to $9.2.
E
Sell
11/3/2021Downgrade
Aion Therapeutic Inc. (AION) was downgraded to E+ from D- on 11/3/2021 due to a large decline in the growth index, solvency index and total return index. Operating cash flow declined 28.85% from -$553.3 to -$712.9.
Aion Therapeutic Inc. (AION) was downgraded to E+ from D- on 11/3/2021 due to a large decline in the growth index, solvency index and total return index. Operating cash flow declined 28.85% from -$553.3 to -$712.9.
D
Sell
9/13/2021Downgrade
Aion Therapeutic Inc. (AION) was downgraded to D- from D on 9/13/2021 due to a noticeable decline in the total return index, solvency index and valuation index. The quick ratio declined from 0.38 to 0.3.
Aion Therapeutic Inc. (AION) was downgraded to D- from D on 9/13/2021 due to a noticeable decline in the total return index, solvency index and valuation index. The quick ratio declined from 0.38 to 0.3.
D
Sell
12/15/2020Upgraded
Aion Therapeutic Inc. (AION) was upgraded to D from D- on 12/15/2020 due to a noticeable increase in the total return index and volatility index.
Aion Therapeutic Inc. (AION) was upgraded to D from D- on 12/15/2020 due to a noticeable increase in the total return index and volatility index.
D
Sell
11/30/2020Downgrade
Aion Therapeutic Inc. (AION) was downgraded to D- from D on 11/30/2020 due to a decline in the volatility index and total return index.
Aion Therapeutic Inc. (AION) was downgraded to D- from D on 11/30/2020 due to a decline in the volatility index and total return index.
D
Sell
11/12/2020Upgraded
Aion Therapeutic Inc. (AION) was upgraded to D from D- on 11/12/2020 due to an increase in the volatility index.
Aion Therapeutic Inc. (AION) was upgraded to D from D- on 11/12/2020 due to an increase in the volatility index.
D
Sell
10/27/2020Downgrade
Aion Therapeutic Inc. (AION) was downgraded to D- from D on 10/27/2020 due to a noticeable decline in the growth index, volatility index and valuation index. Operating cash flow declined 258.91% from $222.2 to -$353.1, EBIT declined 105.51% from -$159.7 to -$328.2, and earnings per share declined from -$0.0061 to -$0.0074.
Aion Therapeutic Inc. (AION) was downgraded to D- from D on 10/27/2020 due to a noticeable decline in the growth index, volatility index and valuation index. Operating cash flow declined 258.91% from $222.2 to -$353.1, EBIT declined 105.51% from -$159.7 to -$328.2, and earnings per share declined from -$0.0061 to -$0.0074.
D
Sell
7/13/2020Upgraded
Osoyoos Cannabis Inc. (OSO) was upgraded to D from D- on 7/13/2020 due to a major increase in the growth index, total return index and volatility index. Operating cash flow increased 221.22% from -$183.3 to $222.2.
Osoyoos Cannabis Inc. (OSO) was upgraded to D from D- on 7/13/2020 due to a major increase in the growth index, total return index and volatility index. Operating cash flow increased 221.22% from -$183.3 to $222.2.
D
Sell
5/20/2020Upgraded
Osoyoos Cannabis Inc. (OSO) was upgraded to D- from E+ on 5/20/2020 due to an increase in the growth index, volatility index and solvency index.
Osoyoos Cannabis Inc. (OSO) was upgraded to D- from E+ on 5/20/2020 due to an increase in the growth index, volatility index and solvency index.
E
Sell
3/27/2020Downgrade
Osoyoos Cannabis Inc. (OSO) was downgraded to E+ from D- on 3/27/2020 due to a major decline in the growth index, total return index and solvency index. Earnings per share declined from $0.0088 to -$0.0076, operating cash flow declined 38.86% from -$132 to -$183.3, and the quick ratio declined from 2.69 to 1.89.
Osoyoos Cannabis Inc. (OSO) was downgraded to E+ from D- on 3/27/2020 due to a major decline in the growth index, total return index and solvency index. Earnings per share declined from $0.0088 to -$0.0076, operating cash flow declined 38.86% from -$132 to -$183.3, and the quick ratio declined from 2.69 to 1.89.
D
Sell
3/16/2020Upgraded
Osoyoos Cannabis Inc. (OSO) was upgraded to D- from E+ on 3/16/2020 due to an increase in the volatility index, total return index and valuation index.
Osoyoos Cannabis Inc. (OSO) was upgraded to D- from E+ on 3/16/2020 due to an increase in the volatility index, total return index and valuation index.
E
Sell
2/27/2020Downgrade
Osoyoos Cannabis Inc. (OSO) was downgraded to E+ from D- on 2/27/2020 due to a decline in the volatility index.
Osoyoos Cannabis Inc. (OSO) was downgraded to E+ from D- on 2/27/2020 due to a decline in the volatility index.
D
Sell
2/12/2020Upgraded
Osoyoos Cannabis Inc. (OSO) was upgraded to D- from E+ on 2/12/2020 due to an increase in the volatility index.
Osoyoos Cannabis Inc. (OSO) was upgraded to D- from E+ on 2/12/2020 due to an increase in the volatility index.
E
Sell
1/10/2020Downgrade
Osoyoos Cannabis Inc. (OSO) was downgraded to E+ from D- on 1/10/2020 due to a decline in the total return index, volatility index and efficiency index. Total capital declined 9.06% from $3.02M to $2.74M.
Osoyoos Cannabis Inc. (OSO) was downgraded to E+ from D- on 1/10/2020 due to a decline in the total return index, volatility index and efficiency index. Total capital declined 9.06% from $3.02M to $2.74M.
D
Sell
11/5/2019Upgraded
Osoyoos Cannabis Inc. (OSO) was upgraded to D- from E on 11/5/2019 due to an increase in the valuation index and growth index. Earnings per share increased from -$0.0195 to -$0.0115.
Osoyoos Cannabis Inc. (OSO) was upgraded to D- from E on 11/5/2019 due to an increase in the valuation index and growth index. Earnings per share increased from -$0.0195 to -$0.0115.
E
Sell
9/6/2019Downgrade
Osoyoos Cannabis Inc. (OSO) was downgraded to E from E+ on 9/6/2019 due to a noticeable decline in the volatility index, efficiency index and total return index. Net income declined 67.38% from -$357.1 to -$597.7, and total capital declined 10.12% from $3.16M to $2.84M.
Osoyoos Cannabis Inc. (OSO) was downgraded to E from E+ on 9/6/2019 due to a noticeable decline in the volatility index, efficiency index and total return index. Net income declined 67.38% from -$357.1 to -$597.7, and total capital declined 10.12% from $3.16M to $2.84M.
E
Sell
8/1/2019Upgraded
Osoyoos Cannabis Inc. (OSO) was upgraded to E+ from E- on 8/1/2019 due to a noticeable increase in the efficiency index, total return index and volatility index.
Osoyoos Cannabis Inc. (OSO) was upgraded to E+ from E- on 8/1/2019 due to a noticeable increase in the efficiency index, total return index and volatility index.
E
Sell
5/16/2019None
Aion Therapeutic Inc. (AION) was downgraded to E- from U on 05/16/2019.
Aion Therapeutic Inc. (AION) was downgraded to E- from U on 05/16/2019.
